Noteworthy, increased expression of GLI2 was associated with the presence of FLT3 mutations and correlated with a significantly shortened event-free, relapse-free, and overall AML patient survival (Wellbrock et al., 2015). This evidence concerns the gene GLI2 and acute myeloid leukemia.